sulfamidase Inhibitors
The term sulfamidase inhibitors predominantly denotes agents that can modulate or reduce the function of sulfamidase. While no direct inhibitors of sulfamidase have been cataloged, certain chemicals are known to influence its activity by targeting the associated pathways. For instance, agents that modulate glycosaminoglycan (GAG) synthesis can affect the substrate availability for sulfamidase. Genistein and Propranolol stand as exemplars in this regard, with the former inhibiting tyrosine kinases, thereby influencing cell growth and differentiation signals that play a pivotal role in GAG synthesis. The latter, a beta-adrenergic antagonist, exhibits potential in diminishing GAG synthesis in certain cellular contexts.
Simultaneously, the integrity and function of lysosomes, where sulfamidase operates, serve as another pivotal point of intervention. Chloroquine and its analog, Hydroxychloroquine, by raising the pH of lysosomes, can challenge the enzymatic activity milieu that sulfamidase necessitates. A similar impediment arises with Ammonium chloride, which alkalizes lysosomes. Conversely, agents like Methyl-β-cyclodextrin, which disrupt lipid rafts, could indirectly influence endocytosis and lysosomal operations. On another spectrum, agents such as Castanospermine and Swainsonine can deter glycoprotein processing, exerting indirect effects on the lysosomal environment and the enzymes therein, including sulfamidase
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Inhibits tyrosine kinases, reducing cell growth and differentiation signals involved in GAG synthesis. Reduced GAG synthesis may indirectly reduce substrate availability for sulfamidase. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Raises the pH of lysosomes, potentially inhibiting lysosomal enzymes, including sulfamidase, by creating a less favorable environment for their activity. | ||||||
hydroxychloroquine | 118-42-3 | sc-507426 | 5 g | $57.00 | 1 | |
Similar to Chloroquine, it increases lysosomal pH, which can suppress sulfamidase's optimal activity within the lysosome. | ||||||
Methyl-β-cyclodextrin | 128446-36-6 | sc-215379A sc-215379 sc-215379C sc-215379B | 100 mg 1 g 10 g 5 g | $20.00 $48.00 $160.00 $82.00 | 19 | |
Disrupts lipid rafts in membranes. Since lipid rafts are pivotal for endocytosis and lysosomal function, disrupting them can impair sulfamidase substrate entry into lysosomes. | ||||||
FCM Lysing solution (1x) | sc-3621 | 150 ml | $62.00 | 8 | ||
Alkalizes lysosomes, which can interfere with sulfamidase's optimal pH range, thereby potentially decreasing its enzymatic activity. | ||||||
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
As a beta-adrenergic antagonist, it can reduce GAG synthesis in some cells. With less GAG synthesis, there's potentially less substrate for sulfamidase to act upon. | ||||||
Castanospermine | 79831-76-8 | sc-201358 sc-201358A | 100 mg 500 mg | $184.00 $632.00 | 10 | |
Inhibits alpha-glucosidase I, affecting N-linked glycosylation. By altering glycoprotein processes in the lysosome, it may indirectly impact the environment and potentially the activity of sulfamidase. | ||||||
Swainsonine | 72741-87-8 | sc-201362 sc-201362C sc-201362A sc-201362D sc-201362B | 1 mg 2 mg 5 mg 10 mg 25 mg | $138.00 $251.00 $631.00 $815.00 $1832.00 | 6 | |
An inhibitor of alpha-mannosidase, which affects N-linked glycosylation. Disrupted glycoprotein processing can indirectly alter lysosomal function and thus sulfamidase activity. | ||||||
Deoxynojirimycin | 19130-96-2 | sc-201369 sc-201369A | 1 mg 5 mg | $73.00 $145.00 | ||
Similar to Nojirimycin, its inhibition of alpha-glucosidase can lead to an altered lysosomal environment, possibly affecting sulfamidase activity. | ||||||
U 18666A | 3039-71-2 | sc-203306 sc-203306A | 10 mg 50 mg | $143.00 $510.00 | 2 | |
Induces a phenotype mimicking Niemann-Pick disease type C, with disturbed cholesterol transport and lysosomal dysfunction. This altered lysosomal environment can hinder sulfamidase activity. | ||||||